Best Stocks Under $2 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $2.00 (2 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Ur Energy NYSEAMERICAN:URG$1.50 0.00 (0.00%) Closing price 06/18/2026 04:10 PM EasternExtended Trading$1.52 +0.02 (+1.67%) As of 06/18/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur EnergyMarket Capitalization$596 millionConsensus RatingBuyConsensus Price Target$2.57 (+71.1% Upside)Volume47.05 million sharesAverage Volume13.91 million sharesToday's Range$1.45▼$1.62 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. iBio NASDAQ:IBIO$1.69 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.68 0.00 (-0.30%) As of 06/18/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBioMarket Capitalization$83.96 millionConsensus RatingBuyConsensus Price Target$5.00 (+195.9% Upside)Volume911,548 sharesAverage Volume752,509 sharesToday's Range$1.61▼$1.733. Inhibikase Therapeutics NASDAQ:IKT$1.83 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.82 -0.01 (-0.27%) As of 06/18/2026 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Inhibikase Therapeutics, Inc, a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. More about Inhibikase TherapeuticsMarket Capitalization$241.62 millionConsensus RatingBuyConsensus Price Target$5.40 (+195.1% Upside)Volume1.48 million sharesAverage Volume533,728 sharesToday's Range$1.71▼$1.834. Stereotaxis NYSEAMERICAN:STXS$1.88 0.00 (0.00%) Closing price 06/18/2026 04:10 PM EasternExtended Trading$1.88 +0.01 (+0.27%) As of 06/18/2026 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More about StereotaxisMarket Capitalization$183.74 millionConsensus RatingBuyConsensus Price Target$3.88 (+106.1% Upside)Volume814,264 sharesAverage Volume330,463 sharesToday's Range$1.77▼$1.915. Peraso NASDAQ:PRSO$0.91 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$0.90 0.00 (-0.51%) As of 06/18/2026 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Peraso Inc, a fabless semiconductor company, develops, markets, and sells semiconductor devices and modules. The company's products include millimeter wavelength (mmWave) ICs, including baseband IC, various mmWave radio frequency, integrated circuits, as well as associated antenna technology; and mmWave antenna modules. More about PerasoMarket Capitalization$13.38 millionConsensus RatingBuyConsensus Price Target$3.00 (+230.5% Upside)Volume468,160 sharesAverage Volume645,786 sharesToday's Range$0.90▼$0.926. Autolus Therapeutics NASDAQ:AUTL$1.51 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.51 +0.00 (+0.13%) As of 06/18/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. More about Autolus TherapeuticsMarket Capitalization$401.89 millionConsensus RatingModerate BuyConsensus Price Target$8.75 (+479.5% Upside)Volume843,810 sharesAverage Volume1.20 million sharesToday's Range$1.51▼$1.597. Context Therapeutics NASDAQ:CNTX$0.63 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$0.63 0.00 (-0.46%) As of 06/18/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context TherapeuticsMarket Capitalization$58.06 millionConsensus RatingModerate BuyConsensus Price Target$6.17 (+875.9% Upside)Volume3.08 million sharesAverage Volume2.35 million sharesToday's Range$0.59▼$0.648. Palisade Bio NASDAQ:PALI$1.87 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.86 -0.01 (-0.27%) As of 06/18/2026 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Palisade Bio, Inc, a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. More about Palisade BioMarket Capitalization$324.59 millionConsensus RatingModerate BuyConsensus Price Target$10.20 (+445.5% Upside)Volume4.04 million sharesAverage Volume2.42 million sharesToday's Range$1.79▼$1.939. Real Brokerage NASDAQ:REAX$1.76 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.78 +0.02 (+1.08%) As of 06/18/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.The Real Brokerage Inc, together with its subsidiaries, operates as a real estate technology company in the United States and Canada. More about Real BrokerageMarket Capitalization$375.76 millionConsensus RatingModerate BuyConsensus Price Target$5.69 (+223.2% Upside)Volume3.19 million sharesAverage Volume3.03 million sharesToday's Range$1.71▼$1.8010. Nouveau Monde Graphite NYSE:NMG$1.56 -0.02 (-0.95%) Closing price 06/18/2026 03:59 PM EasternExtended Trading$1.58 +0.01 (+0.64%) As of 06/18/2026 07:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nouveau Monde Graphite Inc engages in the acquisition, exploration, development, and evaluation of mineral properties in Quebec, Canada. More about Nouveau Monde GraphiteMarket Capitalization$254.11 millionConsensus RatingModerate BuyConsensus Price Target$4.67 (+198.2% Upside)Volume722,971 sharesAverage Volume835,277 sharesToday's Range$1.54▼$1.5911. Tenaya Therapeutics NASDAQ:TNYA$0.73 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$0.73 +0.00 (+0.33%) As of 06/18/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tenaya Therapeutics, Inc, a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. More about Tenaya TherapeuticsMarket Capitalization$158.54 millionConsensus RatingModerate BuyConsensus Price Target$4.00 (+447.5% Upside)Volume2.55 million sharesAverage Volume3.03 million sharesToday's Range$0.69▼$0.7412. Nano-X Imaging NASDAQ:NNOX$1.67 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.70 +0.03 (+1.86%) As of 06/18/2026 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. More about Nano-X ImagingMarket Capitalization$116.22 millionConsensus RatingModerate BuyConsensus Price Target$5.00 (+199.4% Upside)Volume1.47 million sharesAverage Volume1.06 million sharesToday's Range$1.67▼$1.8113. Metagenomi NASDAQ:MGX$1.20 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.22 +0.02 (+1.25%) As of 06/18/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Metagenomi, Inc, a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. More about MetagenomiMarket Capitalization$45.18 millionConsensus RatingModerate BuyConsensus Price Target$9.00 (+650.0% Upside)Volume190,282 sharesAverage Volume152,519 sharesToday's Range$1.19▼$1.2314. enCore Energy NASDAQ:EU$1.65 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.64 -0.01 (-0.91%) As of 06/18/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. More about enCore EnergyMarket Capitalization$320.51 millionConsensus RatingModerate BuyConsensus Price Target$3.83 (+132.3% Upside)Volume12.41 million sharesAverage Volume3.49 million sharesToday's Range$1.60▼$1.7515. DeFi Technologies NASDAQ:DEFT$0.56 +0.00 (+0.07%) Closing price 06/18/2026 03:59 PM EasternExtended Trading$0.56 +0.00 (+0.89%) As of 06/18/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.DeFi Technologies, Inc engages in the provision of investment services. It plans to acquire equity, debt, or other securities of publicly traded or private companies or other entities. More about DeFi TechnologiesMarket Capitalization$216.76 millionP/E Ratio3.99Consensus RatingModerate BuyConsensus Price Target$2.00 (+257.8% Upside)Volume4.43 million sharesAverage Volume4.35 million shares16. Humacyte NASDAQ:HUMA$0.92 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$0.94 +0.02 (+1.80%) As of 06/18/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Humacyte, Inc engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. More about HumacyteMarket Capitalization$205.23 millionConsensus RatingModerate BuyConsensus Price Target$6.25 (+576.1% Upside)Volume11.29 million sharesAverage Volume8.26 million sharesToday's Range$0.90▼$1.0017. SelectQuote NYSE:SLQT$0.98 0.00 (-0.45%) Closing price 06/18/2026 03:59 PM EasternExtended Trading$0.99 +0.01 (+0.51%) As of 06/18/2026 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. More about SelectQuoteMarket Capitalization$174.30 millionConsensus RatingModerate BuyConsensus Price Target$3.00 (+204.9% Upside)Volume1.49 million sharesAverage Volume1.46 million sharesToday's Range$0.97▼$1.0118. Biomea Fusion NASDAQ:BMEA$1.18 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.18 +0.00 (+0.17%) As of 06/18/2026 07:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Biomea Fusion, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. More about Biomea FusionMarket Capitalization$85.31 millionConsensus RatingModerate BuyConsensus Price Target$8.50 (+620.3% Upside)Volume744,055 sharesAverage Volume898,645 sharesToday's Range$1.16▼$1.2619. Black Diamond Therapeutics NASDAQ:BDTX$1.66 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.67 +0.01 (+0.60%) As of 06/18/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Black Diamond Therapeutics, Inc, a clinical-stage oncology medicine company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. More about Black Diamond TherapeuticsMarket Capitalization$95.12 millionConsensus RatingModerate BuyConsensus Price Target$10.00 (+502.4% Upside)Volume1.91 million sharesAverage Volume1.43 million sharesToday's Range$1.62▼$1.7320. PepGen NASDAQ:PEPG$1.79 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.76 -0.03 (-1.40%) As of 06/18/2026 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.PepGen Inc, a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. More about PepGenMarket Capitalization$123.81 millionConsensus RatingModerate BuyConsensus Price Target$11.50 (+542.5% Upside)Volume690,672 sharesAverage Volume582,255 sharesToday's Range$1.72▼$1.8121. InflaRx NASDAQ:IFRX$1.80 -0.01 (-0.28%) Closing price 06/18/2026 03:59 PM EasternExtended Trading$1.81 +0.01 (+0.28%) As of 06/18/2026 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. More about InflaRxMarket Capitalization$130.85 millionConsensus RatingModerate BuyConsensus Price Target$7.00 (+287.8% Upside)Volume1.49 million sharesAverage Volume1.09 million sharesToday's Range$1.75▼$1.8922. ALX Oncology NASDAQ:ALXO$1.53 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.48 -0.05 (-3.27%) As of 06/18/2026 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ALX Oncology Holdings Inc, a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. More about ALX OncologyMarket Capitalization$205.88 millionConsensus RatingModerate BuyConsensus Price Target$4.60 (+200.7% Upside)Volume5.05 million sharesAverage Volume1.42 million sharesToday's Range$1.41▼$1.5523. MediciNova NASDAQ:MNOV$1.32 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.32 +0.00 (+0.38%) As of 06/18/2026 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.MediciNova, Inc, a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. More about MediciNovaMarket Capitalization$64.97 millionConsensus RatingModerate BuyConsensus Price Target$8.33 (+531.3% Upside)Volume34,840 sharesAverage Volume40,220 sharesToday's Range$1.32▼$1.3424. Gain Therapeutics NASDAQ:GANX$1.88 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.87 -0.01 (-0.37%) As of 06/18/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Gain Therapeutics, Inc, a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. More about Gain TherapeuticsMarket Capitalization$80.19 millionConsensus RatingModerate BuyConsensus Price Target$8.50 (+352.1% Upside)Volume499,893 sharesAverage Volume643,554 sharesToday's Range$1.80▼$1.9025. SKYX Platforms NASDAQ:SKYX$1.08 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.08 +0.00 (+0.46%) As of 06/18/2026 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.SKYX Platforms Corp. provides a series of safe-smart platform technologies. The company's first and second-generation technologies enable light fixtures, ceiling fans, and other electrically wired products to be installed and plugged into a ceiling's electrical outlet box. More about SKYX PlatformsMarket Capitalization$145.24 millionConsensus RatingModerate BuyConsensus Price Target$5.00 (+363.0% Upside)Volume1.39 million sharesAverage Volume1.18 million sharesToday's Range$1.03▼$1.09 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/15 - 06/19 Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally? Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself? Why Kroger’s Pullback Could Be a Gift for Patient Investors Credo Technologies Accelerates AI—Its Stock Price Will Follow Why Rocket Lab’s Nasdaq-100 Moment Could Change the Story Why Palantir’s Google Cloud Deal Could Change the Debate Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
